Recruiting OBSERVATIONAL NCT06283160

METabolomic and Immune PROfiling in the Development of Pancreatic Fistulas After cepHalic duodEnopancreatectomy (PROMETHEE)

Interest of Metabolomic and Immune Profiling in the Development of Pancreatic Fistulas After Duodenopancreatectomy

Sponsor: Centre Hospitalier Universitaire de Besancon

Conditions Acute Pancreatitis Pancreatic Fistula Pancreatoduodenectomy

Updated 5 times since 2024 Last updated: Oct 10, 2024 Started: Mar 1, 2024 Primary completion: May 30, 2026 Completion: May 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06283160, this observational or N/A phase trial focuses on Acute Pancreatitis and Pancreatic Fistula and remains actively recruiting participants. Sponsored by Centre Hospitalier Universitaire de Besancon, it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Nov 2024 — Present [monthly]

Recruiting
Sep 2024 — Nov 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
May 2024 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Mar 2024 — May 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Besancon

Data source: Centre Hospitalier Universitaire de Besancon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Besançon, France